5433492026-06-02Disclosure35433492026-06-02Disclosure25433492026-06-02Disclosure15433492026-06-02xbrli:sharesxbrli:pureiso4217:INR

Prohibition of Insider Trading


ACUTAAS CHEMICALS LIMITED

General information about company

Scrip Code543349
NSE SymbolACUTAAS
MSEI SymbolNOTLISTED
Name of the SignatoryEKTA KUMARI SRIVASTAVA
Designation of SignatoryCompany Secretary and Compliance Officer
PlaceSURAT
Date of Filing02-06-2026
ISIN CodeINE00FF01025
Disclosure under RegulationRegulation 7 (2)
Revised FilingNo

PIT Disclosure

Sr. No.Type of instrumentDescription of type of instrument (applicable in case of other is selected)Category of personName of the personCIN / DINSecurities held prior to acquisition / disposalSecurities acquired / disposedSecurities held post acquisition / disposalDate of allotment advice / acquisition of shares / sale of shares specifyMode of acquisition / disposalDate of intimation to companyType of contractContract specificationBuySellExchange on which the trade was executedNotes
No. of security% of shareholdingNo. of securityValue of security (in Rs.)Transaction typeNo. of security% of shareholdingFrom dateTo dateNotional valueNo. of units (contracts × lot size)Notional valueNo. of units (contracts × lot size)
1EquityDirectorVirendra Nath Mishra078154906600000.81%40000123,621,200.00Sell6200000.76%29-05-202629-05-2026Market Sale01-06-2026NSE
2EquityDirectorVirendra Nath Mishra078154906200000.76%119374,325.00Buy6201190.76%29-05-202629-05-2026Market Purchase01-06-2026NSETextual Information(1)
3Government SecurityDirectorVirendra Nath Mishra078154906201190.76%11936,777,307.00Sell6200000.76%29-05-202629-05-2026Market Sale01-06-2026NSETextual Information(2)

Text Block

Textual Information(1)In addition to the precleared sale transaction of 40,000 equity shares of the Company, inadvertently buy and reverse sale transaction of additional 119 number of equity shares of the Company were executed by the reportee.
Textual Information(2)In addition to the precleared sale transaction of 40,000 equity shares of the Company, inadvertently buy and reverse sale transaction of additional 119 number of equity shares of the Company were executed by the reportee.